Johns Hopkins All Children's Hospital Inc.

02/02/2023 | News release | Distributed by Public on 02/02/2023 08:36

Dr. Tamara New Aims to Take Sickle Cell Program to New Heights

Programs

Dr. Tamara New Aims to Take Sickle Cell Program to New Heights

Posted on Feb 02, 2023 by Mike Stephenson

Tamara New, M.D., is the director of the sickle cell disease program at Johns Hopkins All Children's
×

Tamara New, M.D., is the director of the sickle cell disease program at Johns Hopkins All Children's

Close

Tamara New, M.D., has known Cassandra Josephson, M.D., since their undergraduate days at Smith College in Northampton, Massachusetts.

New and Josephson followed similar career paths, each studying pediatric hematology-oncology and landing at Children's Healthcare of Atlanta and Emory University where they worked together for nearly 15 years.

After Josephson left to become director of the Johns Hopkins All Children's Cancer & Blood Disorders Institute in St. Petersburg, Florida, New and her husband, Leonza, came for a visit and decided this would be a great place to live and work.

New started a discussion with Josephson, who had an opening for director of the sickle cell disease program, New's specialty.

"Then I came and met folks here and really fell in love with the place and what the program was doing here," says New, who has four adult children with Leonza.

New joined the Johns Hopkins All Children's medical staff in January and now leads one of the largest sickle cell programs on Florida's west coast. She talked recently about her background and how she chose her specialty.

Did you always want to be a doctor?

I always wanted to be a doctor. From the time I was about 3 years old, I said I wanted to be a doctor and people would try to talk me into other things. Dad was an engineer and thought I would make a great engineer, but I told him no. I want to be a doctor.

What pulled you toward medicine?

Mother was a nurse, and I had a cousin who was much older than me. When I was young, she aspired to become a doctor. She ended up becoming a Ph.D., not a medical doctor.

How did you come to choose sickle cell disease as your specialty?

When I was in medical school, I had a mentor who was a pediatric hematologist-oncologist and he made it seem fun to take care of patients with cancer and blood disorders. Then when I went to residency, in taking care of patients with sickle cell, I felt like I resonated with them. Not because I ever had any family members with sickle cell or knew anybody with sickle cell. But I just felt like they needed an advocate. I was fortunate that the resident who was supervising me when I met my first sickle cell patient as a medical student was very, very compassionate and was very gentle with the patient and explained to me how devastating the pain these patients have and how we could help. That inspired me.

Sometimes people will ask me why sickle cell? For me, part of it is because it is a disease that predominantly effects African Americans and Latino Americans. It is a disease that patients can sometimes become stigmatized and misunderstood and so my goal is to help people understand the complexities of the disease. Every patient is different.

Most people don't understand the pain sickle cell patients endure. Can you speak to that?

This resident described it to me as the worst pain that a patient could have. It's worse than having a kidney stone, worse than a woman in labor because it can be all over. It may not affect just one part of the body. That stuck with me.

When I was in my fellowship training at Columbia University, I had a young patient who, when our pain service asked her what her pain felt like, she said it feels like you're peeling my muscles off of my bone. And she was 6 years old.

Some new sickle cell medications have come on the market in recent years, but it seems fewer patients than might be expected are using them. Can you address that?

For about 25-30 years, we have had hydroxyurea and so families are very familiar with hydroxyurea, but still not everybody wants to use it. It is considered chemotherapy and has to be monitored. So sometimes they don't want to come as frequently to the hospital or they may be nervous about the side effects from the medication.

These newer medications have been around now for two to three years, mostly, and so I believe the patient community is still assessing how much comfort they have with some of these medications.

I love that my patients now have more options than they did 10-15 years ago. I am hopeful that now that we have these new agents that these companies will continue to come up with other agents that have better safety profiles and fewer undesired side effects.

What's something people might find surprising about you?

I'm from York, Maine. My parents were both from Alabama, but my father got a job in Maine with the Department of Defense as an engineer and brought my mom there. They got married there and raised me and my sister there.

What do you do to take your mind off work?

Pre-pandemic, my husband and I would love to go to the opera or Broadway shows. We would go to the movie theater almost every Friday night. That was our date night. We have a strong faith and so church is also part - usually a big part - of our weekends and then family.

Post-pandemic we transitioned to watching movies and series on Netflix and Hulu and things like that but also finding new outdoor spaces to explore. We're new to Florida and the St. Pete/Tampa Bay area so we're excited to discover some fun outdoor places.

RSS 2.0

Related Articles

A (Virtual) World of Relief from Pain

Posted on Sep 20, 2022 in General News

With comprehensive care from medical experts with the hospital's Sickle Cell Disease Program, Abihannah has made progress. Pain medications and a range of therapies have been helpful to her, but the challenge to control her pain has remained a difficult one. During a recent hospital stay, her care team decided to try something different. She was guided into a virtual artistic world - one that took her away from the reality of her hospital bed, away from her persistent pain.

A Transformative Journey

Posted on Sep 09, 2022 in General News

In July, Cassandra Josephson, M.D., became director of the Cancer & Blood Disorders Institute. She is grateful for the opportunity to lead a program where her memories are plentiful from her days as a medical student at the USF College of Medicine, doing her pediatric rotation here at All Children's back in the early '90s. She sees outstanding potential in this institution with its vision of embedding research with clinical care.

C is for Chloe

Posted on Aug 31, 2022 in General News

In March, after five years of being cancer free - Chloe's care team would detect a different kind of cancer - this time, cancer of the thyroid. She was first diagnosed as a toddler, back in 2015, with a type of lung cancer called pleuropulmonary blastoma. But despite the difficult news - there is more hope than ever for children like Chloe.

More Articles

Dr. Tamara New Aims to Take Sickle Cell Program to New Heights

Posted on Feb 02, 2023 in Programs

Tamara New, M.D., knew she wanted to be a doctor since the age of 3, and became inspired to specialize in sickle cell disease during her residency. Dr. New, who recently joined Johns Hopkins All Children's as director of the sickle cell disease program, talks about what drew her to medicine and how she first had the opportunity to connect with patients with sickle cell.

A Patient Blossoms into a CVICU Nurse

Posted on Feb 01, 2023 in Programs

Sherry Dourm is a former patient of Johns Hopkins All Children's Hospital and now a registered nurse helping to take care of children in the cardiovascular intensive care unit (CVICU).

Johns Hopkins All Children's Study Examines Factors Affecting Pediatric Thyroidectomy Outcomes

Posted on Jan 20, 2023 in Research

Shorter hospital stays and fewer readmissions come with higher levels of surgical care.